NT5E and neoplasm: In the same study, in a breast cancer mouse model, the authors demonstrated that CD73 overexpression on tumor cells determines chemoresistance to anthracycline treatment, while the blockade of the enzyme improved antitumor immune response (Loi et al., 2013).